Jim McNinch

Senior Director, Thought Leader Liaisons at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Jim McNinch's Colleagues at Alnylam Pharmaceuticals
Lima Chutkan

Associate Director, Medical Writing

Contact Lima Chutkan

George Beran

Associate Director, Thought Leader Liaison

Contact George Beran

Katie Cafferky

Director, Medical Writing

Contact Katie Cafferky

Narayana Chatla

Associate Director, Process Chemistry

Contact Narayana Chatla

Dione Wu

Patient Recruitment and Retention Specialist

Contact Dione Wu

Joanna Pearson

Patient Education Liaison

Contact Joanna Pearson

View All Jim McNinch's Colleagues
Jim McNinch's Contact Details
HQ
(617) 551-8200
Location
Charlotte, North Carolina, United States
Company
Alnylam Pharmaceuticals
Jim McNinch's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Jim McNinch
Jim McNinch currently works for Alnylam Pharmaceuticals.
Jim McNinch's role at Alnylam Pharmaceuticals is Senior Director, Thought Leader Liaisons.
Jim McNinch's email address is ***@alnylam.com. To view Jim McNinch's full email address, please signup to ConnectPlex.
Jim McNinch works in the SaaS industry.
Jim McNinch's colleagues at Alnylam Pharmaceuticals are Lima Chutkan, George Beran, Katie Cafferky, Narayana Chatla, David DeSantis, Dione Wu, Joanna Pearson and others.
Jim McNinch's phone number is (617) 551-8200
See more information about Jim McNinch